Courtney D. Armstrong
Known title: DirectorCIK: 0001869319
Courtney D. Armstrong's purchase track record
How the stock did after each of Courtney D. Armstrong's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 5 since May 28, 2025
Stock higher 6 months later
67%
3 months: 50%
Median 6-month return
+20.8%
3 months: +0.3%
Beat the S&P 500
67%
median +9.7% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/27/2026 | VRSN | $6K | pending | pending | — |
| 5/27/2026 | VRSN | $5K | -0.9% | pending | — |
| 2/27/2026 | VRSN | $5K | +25.5% | +28.4% | +12.1% |
| 11/25/2025 | VRSN | $4K | -16.2% | +20.8% | +11.1% |
| 5/28/2025 | VRSN | $4K | +1.5% | -5.6% | +15.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| VRSN | ▲ Buy | Open Market | 14 | $4K | 8/27/2026 | View on chart |
| VRSN | ▲ Buy | Open Market | 5 | $1K | 8/27/2026 | View on chart |
| VRSN | ▲ Buy | Grant | 900 | $0 | 7/20/2026 | View on chart |
| VRSN | ▲ Buy | Open Market | 14 | $4K | 5/27/2026 | View on chart |
| VRSN | ▲ Buy | Open Market | 2 | $714 | 5/27/2026 | View on chart |
| VRSN | ▲ Buy | Open Market | 19 | $4K | 2/27/2026 | View on chart |
| VRSN | ▲ Buy | Open Market | 3 | $712 | 2/27/2026 | View on chart |
| VRSN | ▲ Buy | Open Market | 16 | $4K | 11/25/2025 | View on chart |
| VRSN | ▲ Buy | Grant | 879 | $0 | 7/21/2025 | View on chart |
| VRSN | ▲ Buy | Open Market | 15 | $4K | 5/28/2025 | View on chart |
| VRSN | ▲ Buy | Grant | 1,408 | $0 | 7/22/2024 | View on chart |
| VRSN | ▲ Buy | Grant | 1,179 | $0 | 7/24/2023 | View on chart |
| VRSN | ▲ Buy | Grant | 1,377 | $0 | 7/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
VeriSign Stock Considered Expensive Despite Monopoly
A recent analysis notes that VeriSign’s share price is high relative to its earnings and peers, even though the company holds a dominant position in domain name registration. The stock trades near the top of its 52‑week range and sits above a key support level at $292.94. With a trailing P/E of 32.5 and a modest dividend yield of 1.10%, the valuation is a point of discussion for investors.
VeriSign Stock Considered Expensive Despite Monopoly. A recent analysis notes that VeriSign’s share price is high relative to its earnings and peers, even though the company holds a dominant position in domain name registration. The stock trades near the top of its 52‑week range and sits above a key support level at $292.94. With a trailing P/E of 32.5 and a modest dividend yield of 1.10%, the valuation is a point of discussion for investors.